| Zacks Company Profile for Pfizer Inc. (PFE : NYSE) |
|
|
| |
| • Company Description |
| Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.?The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.
Number of Employees: 79,000 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $52.47 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 26,630,814 shares |
| Shares Outstanding: 5,610.90 (millions) |
| Market Capitalization: $294,403.72 (millions) |
| Beta: 0.76 |
| 52 Week High: $61.71 |
| 52 Week Low: $38.48 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
9.02% |
19.37% |
| 12 Week |
9.95% |
23.58% |
| Year To Date |
-11.14% |
8.55% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
235 EAST 42ND STREET
-
NEW YORK,NY 10017
USA |
ph: 212-733-2323
fax: 302-655-5049 |
None |
http://www.pfizer.com |
|
|
| |
| • General Corporate Information |
Officers
Albert Bourla - Chief Executive Officer and Chairman
Frank A. D'Amelio - Chief Financial Officer and Executive Vice Preside
Jennifer B. Damico - Senior Vice President and Controller
Ronald E. Blaylock - Director
Susan Desmond-Hellmann - Director
|
|
Peer Information
Pfizer Inc. (AGN.)
Pfizer Inc. (ABBV)
Pfizer Inc. (NVO)
Pfizer Inc. (LLY)
Pfizer Inc. (RHHBY)
Pfizer Inc. (JNJ)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Large Cap Pharma
Sector: Medical
CUSIP: 717081103
SIC: 2834
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 07/27/22
|
|
Share - Related Items
Shares Outstanding: 5,610.90
Most Recent Split Date: 7.00 (3.00:1)
Beta: 0.76
Market Capitalization: $294,403.72 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 3.05% |
| Current Fiscal Quarter EPS Consensus Estimate: $2.02 |
Indicated Annual Dividend: $1.60 |
| Current Fiscal Year EPS Consensus Estimate: $6.63 |
Payout Ratio: 0.31 |
| Number of Estimates in the Fiscal Year Consensus: 4.00 |
Change In Payout Ratio: -0.17 |
| Estmated Long-Term EPS Growth Rate: 12.47% |
Last Dividend Paid: 05/12/2022 - $0.40 |
| Next EPS Report Date: 07/27/22 |
|
|
|
| |
